Physician profile
Dawn Varner Herzig
NPI 1770549560
$1,184.29
in general payments reported to CMS, 2019-2025
17 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.39 · 2021: $241 · 2022: $126 · 2023: $218 · 2024: $304 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $348.13 | 2022-2025 | Eylea Hd, Eylea |
| Horizon Therapeutics Plc | $144.99 | 2021-2023 | Tepezza |
| Amgen INC. | $122.96 | 2024 | Tepezza |
| Apellis Pharmaceuticals, INC. | $104.25 | 2022-2025 | Syfovre |
| Genentech USA, INC. | $67.93 | 2023-2025 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $67.65 | 2021 | |
| Aerie Pharmaceuticals, INC. | $65.22 | 2019-2021 | |
| Astellas Pharma US INC | $43.51 | 2025 | Izervay |
| Johnson & Johnson Vision Care, INC. | $41.50 | 2023-2025 | Acuvue |
| Alcon Vision LLC | $31.20 | 2019-2023 | Rocklatan |
| Genentech, INC. | $30.53 | 2025 | Vabysmo |
| Ani Pharmaceuticals, INC. | $27.88 | 2025 | Purified Cortrophin Gel |
| Glaukos Corporation | $21.99 | 2025 | Istent Infinite |
| Eyepoint US, INC. | $19.62 | 2022 | |
| Quidel Corporation | $16.78 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $15.25 | 2024 | Zylet, Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Herzig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.